Van Eck Associates Corp Rx Sight, Inc. Transaction History
Van Eck Associates Corp
- $88.3 Billion
- Q2 2025
A detailed history of Van Eck Associates Corp transactions in Rx Sight, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 85 shares of RXST stock, worth $730. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85
Previous 4,481
98.1%
Holding current value
$730
Previous $113,000
99.12%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RXST
# of Institutions
183Shares Held
36.6MCall Options Held
42.2KPut Options Held
103K-
Ra Capital Management, L.P. Boston, MA3.7MShares$31.8 Million1.05% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$20.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$19.6 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.77MShares$15.2 Million0.08% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.32MShares$11.4 Million0.01% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $237M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...